[1]
K. V. Levandowska 2022. IMPROVING THE USE OF MYOCARDIAL CYTOPROTECTORS AS A METABOLIC THERAPY OF PATIENTS WITH DECOMPENSATED HEART FAILURE IN THE EARLY AND LATE POST-INFARCE PERIOD. PRECARPATHIAN BULLETIN OF THE SHEVCHENKO SCIENTIFIC SOCIETY Pulse. 18 (66) (Dec. 2022), 69–83. DOI:https://doi.org/10.21802/2304-7437-2022-18(66)-69-83.